You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Monique M. Greer

Senior Vice President, Investor Relations & Corporate Communications at Cascadian Therapeutics, Inc.
Relationship Science aggregates deep and verified information on over 6 million influential decision makers and the over 1.5 million organizations with which they are associated. From this data, we create a "business social graph" that highlights who knows whom. Here are Monique M. Greer's strongest connections.

People Most Closely Connected to Monique M. Greer

Click the names below to expand relationship details.
Marc L. Lesnick
Senior Vice President, Regulatory Affairs & Quality at Cascadian Therapeutics, Inc.
Scott D. Myers
President, Chief Executive Officer & Director at Cascadian Therapeutics, Inc.
Julia Eastland
Chief Financial Officer & Chief Business Officer at Cascadian Therapeutics, Inc.
Christopher S. Henney
Former Interim Chief Executive Officer at Cascadian Therapeutics, Inc.
Gary W. Christianson
Former Chief Operating Officer at Cascadian Therapeutics, Inc.
Scott Robert Peterson
Chief Scientific Officer at Cascadian Therapeutics, Inc.
Lee M. Rauch
Partner at Mitchell Madison Group
Robert L. Kirkman
Former Director, President & Chief Executive Officer at Cascadian Therapeutics, Inc.
T. Alex McPherson
Professor Emeritus at University of Alberta - Faculty of Medicine and Dentistry
Edward A. Taylor
Former Chief Financial Officer, Secretary & Vice President-Administration at Cascadian Therapeutics, Inc.
Ted W. Love
President, Chief Executive Officer & Director at Global Blood Therapeutics, Inc.
Daniel K. Spiegelman
Executive Vice President & Chief Financial Officer at BioMarin Pharmaceutical, Inc.
Steven James
Executive Chairman & Chief Executive Officer at Pionyr Immunotherapeutics, Inc.
Gwen Fyfe
Former Vice President-BioOncology at Genentech, Inc.
Bob Azelby
Executive Vice President, Chief Commercial Officer at Juno Therapeutics, Inc.
Marc C. Chamberlain
Medical Director at Cascadian Therapeutics, Inc.
Richard L. Jackson
Former President & Chief Executive Officer at Ausio Pharmaceuticals
Mark Nathan Lampert
Chief Executive Officer at BVF Partners LP
There are 216 more people accessible only with RelSci Professional.